Kraj: Nowa Zelandia
Język: angielski
Źródło: Medsafe (Medicines Safety Authority)
Tranylcypromine sulfate 13.68mg equivalent to 10 mg tranylcypromine; Tranylcypromine sulfate 13.68mg equivalent to 10 mg tranylcypromine
Boucher & Muir (NZ) Ltd t/a Mercury Pharma (NZ)
Tranylcypromine sulfate 13.68 mg (=10 mg tranylcypromine)
10 mg
Film coated tablet
Active: Tranylcypromine sulfate 13.68mg equivalent to 10 mg tranylcypromine Excipient: Calcium sulfate Carnauba wax Red Spectraspray ACSL0673 Erythrosine Gelatin Hypromellose Magnesium stearate Maize starch Propylene glycol Shellac Sucrose Active: Tranylcypromine sulfate 13.68mg equivalent to 10 mg tranylcypromine Excipient: Calcium sulfate Carnauba wax Erythrosine Gelatin Magnesium stearate Maize starch Opadry red 06H250000 Sucrose
Blister pack, 50 tablets
Prescription
Prescription
Trifarma SpA
Parnate is indicated for the treatment of symptoms of depressive illness especially where treatment with other types of anti-depressants has failed. It is not recommended for use in mild depressive states resulting from temporary situational difficulties.
Package - Contents - Shelf Life: Blister pack, - 50 tablets - 36 months from date of manufacture stored at or below 25°C
1969-12-31
PARNATE CONSUMER MEDICINE INFORMATION Page 1 of 10 PARNATE ® TABLETS (Tranylcypromine 10 mg) CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions about Parnate. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Parnate against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT PARNATE IS USED FOR Parnate is used to treat symptoms of depression, especially if treatment with other types of antidepressants has failed. There are many different types of medicines used to treat depression. Parnate belongs to a group of medicines called monoamine oxidase inhibitor (MAOI) antidepressants. It contains the active ingredient tranylcypromine. Depression is longer lasting or more severe than the ‘low moods’ that everyone has from time to time. It is thought to be caused by a chemical imbalance in parts of the brain. The imbalance affects your whole body and can cause emotional and physical symptoms. You may feel low in spirit, lose interest in usual activities, be unable to enjoy life, have poor appetite or overeat, have disturbed sleep, often waking up early, low energy and feel guilty over nothing. Parnate corrects the chemical imbalance and helps relieve the symptoms of depression. It is not recommended for the ‘low moods’ that everyone has from time to time due to the stress or sadness of everyday life. Your doctor may have prescribed Parnate for another use. ASK YOUR DOCTOR IF YOU HAVE QUESTIONS ABOUT WHY PARNATE HAS BEEN PRESCRIBED FOR YOU. Parnate is available only with a doctor’s prescription. PARNATE CONSUMER MEDICINE INFORMATION Page 2 of 10 BEFORE YOU TAKE PARNATE _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE PARNATE IF YOU HAVE AN ALLERGY TO: • Parnate Przeczytaj cały dokument
1 PARNATE TRANYLCYPROMINE FILM-COATED TABLETS 10 MG 1 NEW ZEALAND DATA SHEET 1 PARNATE ® (10 MG FILM-COATED TABLETS) PARNATE 10 mg film-coated tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Parnate 10 mg film-coated tablets: each tablet contains tranylcypromine sulfate equivalent to 10 mg of tranylcypromine. EXCIPIENTS WITH KNOWN EFFECT: each tablet contains sucrose 6 mg. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Parnate 10 mg film-coated tablets contain "geranium rose" coloured, biconvex, film-coated tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Parnate is indicated for the treatment of symptoms of depressive illness especially where treatment with other types of anti-depressants has failed. It is not recommended for use in mild depressive states resulting from temporary situational difficulties. 4.2 DOSE AND METHOD OF ADMINISTRATION ADULTS Begin with 20 mg a day given as 10 mg in the morning and 10 mg in the afternoon. If there is no satisfactory response after two weeks, add one more tablet at midday. Continue this dosage for at least a week. A dosage of 3 tablets a day should only be exceeded with caution. When a satisfactory response is established, dosage may be reduced to a maintenance level. Some patients will be maintained on 20 mg per day, some will need only 10 mg daily. If no improvement occurs, continued administration is unlikely to be beneficial. 2 PARNATE TRANYLCYPROMINE FILM-COATED TABLETS 10 MG 2 When given together with a tranquilliser, the dosage of Parnate is not affected. When the medicine is given concurrently with electroconvulsive therapy, the recommended dosage is 10 mg twice a day during the series and 10 mg a day afterwards as maintenance therapy. Refer to section 4.4 Special warnings and precautions for use - Stopping treatment section. Special populations _Elderly_ Parnate should not be administered to adults older than 60 years of age. Refer to section 4.3. Paediatric population Parnate is not indicated for children under 18 years of Przeczytaj cały dokument